Design of the clinical study. Credit: Nature (2024). DOI: 10.1038/s41586-024-07725-1 A new method for identifying the pathogens involved in sepsis cases, which could help to select optimal therapeutics, is reported in Nature. The test has the potential to reduce the turnaround times normally associated with developing treatments for infections and may improve patient outcomes. Sepsis, a dysregulated immune response brought on by an infection, is one of the leading causes of death, globally. Patient-specific treatment can be developed using antimicrobial susceptibility testing; however, this typically takes two to three days owing to the need for a blood culture sample, which Read More
No comments:
Post a Comment